Thus, the present findings demonstrated the role and mechanism of FOXD1 in HNSCC cell senescence, suggesting that FOXD1 is a promising therapeutic target for HNSCC. The gene discussed is FOXD1; the disease is head and neck squamous cell carcinoma.